General Information of Drug Transporter (DT)
DT ID DTD0380 Transporter Info
Gene Name SLC4A1
Transporter Name Anion exchange protein 1
Gene ID
6521
UniProt ID
P02730
Post-Translational Modification of This DT
Overview of SLC4A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-N-glycosylation X-O-glycosylation X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X: Amino Acid

Acetylation

  Methionine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A1 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Methionine

Modified Location

1

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC4A1 Methionine 1 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A1 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

642

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC4A1 Asparagine 642 has the potential to affect its expression or activity.

O-glycosylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A1 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

162

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC4A1 Serine 162 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC4A1 [5] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

224

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC4A1 Serine 224 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC4A1 [5] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

745

Experimental Method

Co-Immunoprecipitation

Detailed Description

O-linked Glycosylation at SLC4A1 Serine 745 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        15 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A1 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

29

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 29 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC4A1 [9] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

50

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 50 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC4A1 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

181

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 181 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC4A1 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

185

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 185 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC4A1 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

193

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 193 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC4A1 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

194

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 194 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC4A1 [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

212

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 212 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC4A1 [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

214

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 214 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC4A1 [9] , [14]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

303

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 303 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC4A1 [13] , [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

349

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 349 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SLC4A1 [13] , [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

350

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 350 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence SLC4A1 [15] , [16]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

356

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 356 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence SLC4A1 [13] , [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

357

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 357 has the potential to affect its expression or activity.

  PTM Phenomenon 14

Have the potential to influence SLC4A1 [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

402

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 402 has the potential to affect its expression or activity.

  PTM Phenomenon 15

Have the potential to influence SLC4A1 [12] , [18]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

745

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Serine 745 has the potential to affect its expression or activity.

  Threonine

        10 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A1 [9] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

39

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Threonine 39 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC4A1 [9] , [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

42

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Threonine 42 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC4A1 [9] , [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

44

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Threonine 44 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC4A1 [9] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

48

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Threonine 48 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC4A1 [9] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

49

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Threonine 49 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC4A1 [9] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

54

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Threonine 54 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC4A1 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

197

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Threonine 197 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC4A1 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

208

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Threonine 208 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC4A1 [12] , [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

746

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Threonine 746 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC4A1 [9] , [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

894

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Threonine 894 has the potential to affect its expression or activity.

  Tyrosine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A1 [11] , [19]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

8

Related Enzyme

Tyrosine-protein kinase SYK (SYK)

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Tyrosine 8 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC4A1 [11] , [19]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

21

Related Enzyme

Tyrosine-protein kinase SYK (SYK)

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Tyrosine 21 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC4A1 [9] , [20]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

46

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Tyrosine 46 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC4A1 [12] , [15]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

347

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Tyrosine 347 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC4A1 [11] , [19]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

359

Related Enzyme

Tyrosine-protein kinase Lyn (LYN)

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Tyrosine 359 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC4A1 [17]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

413

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Tyrosine 413 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC4A1 [13]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

818

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Tyrosine 818 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC4A1 [11] , [19]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

904

Related Enzyme

Tyrosine-protein kinase Lyn (LYN)

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A1 Tyrosine 904 has the potential to affect its expression or activity.

S-nitrosylation

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A1 [21] , [22]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

201

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation at SLC4A1 Cystine 201 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC4A1 [21] , [22]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

317

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation at SLC4A1 Cystine 317 has the potential to affect its expression or activity.

S-palmitoylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A1 [23]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

843

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-palmitoylation at SLC4A1 Cystine 843 has the potential to affect its expression or activity.
References
1 Primary structure of the cytoplasmic domain of human erythrocyte protein band 3. Comparison with its sequence in the mouse. Biochim Biophys Acta. 1989 Sep 14;998(1):43-9.
2 Orientation of the band 3 polypeptide from human erythrocyte membranes. Identification of NH2-terminal sequence and site of carbohydrate attachment. J Biol Chem. 1978 Oct 25;253(20):7242-8.
3 A substrate access tunnel in the cytosolic domain is not an essential feature of the solute carrier 4 (SLC4) family of bicarbonate transporters. J Biol Chem. 2013 Nov 22;288(47):33848-33860.
4 Processing of N-linked oligosaccharide depends on its location in the anion exchanger, AE1, membrane glycoprotein. Biochem J. 2000 Jul 1;349(Pt 1):51-7.
5 Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes. Diabetes. 2009 Feb;58(2):309-17.
6 The LIM protein FHL3 binds basic Kruppel-like factor/Kruppel-like factor 3 and its co-repressor C-terminal-binding protein 2. J Biol Chem. 2003 Apr 11;278(15):12786-95.
7 Proteolytic processing and oligomerization of bacteriophage-derived endosialidases. J Biol Chem. 2003 Apr 11;278(15):12634-44.
8 Modulation, via protein-protein interactions, of glyceraldehyde-3-phosphate dehydrogenase activity through redox phosphoribulokinase regulation. J Biol Chem. 2003 Apr 4;278(14):12078-84.
9 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
10 An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
11 Phosphorylation sites in human erythrocyte band 3 protein. Biochim Biophys Acta. 1991 Jan 30;1061(2):253-66.
12 Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3175-3180.
13 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
14 Identification of the major casein kinase I phosphorylation sites on erythrocyte band 3. Blood. 1997 Apr 15;89(8):3019-24.
15 Phosphoproteome profiling revealed abnormally phosphorylated AMPK and ATF2 involved in glucose metabolism and tumorigenesis of GH-PAs. J Endocrinol Invest. 2019 Feb;42(2):137-148.
16 Residual tissue repositories as a resource for population-based cancer proteomic studies. Clin Proteomics. 2018 Aug 3;15:26.
17 An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
18 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
19 Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites. Blood. 2000 Aug 15;96(4):1550-7.
20 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
21 Predict and analyze S-nitrosylation modification sites with the mRMR and IFS approaches. J Proteomics. 2012 Feb 16;75(5):1654-65.
22 Protein thiols and glutathione influence the nitric oxide-dependent regulation of the red blood cell metabolism. Nitric Oxide. 2002 Mar;6(2):186-99.
23 Palmitoylation of cysteine 69 from the COOH-terminal of band 3 protein in the human erythrocyte membrane. Acylation occurs in the middle of the consensus sequence of F--I-IICLAVL found in band 3 protein and G2 protein of Rift Valley fever virus. J Biol Chem. 1991 Sep 5;266(25):16420-4.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.